← Back
Data updated: Mar 10, 2026
PHARMACOSMOS
OncologyCardiovascular
PHARMACOSMOS is a pharmaceutical company focused on Oncology, Cardiovascular. Key products include MONOFERRIC.
2020
Since
2
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 67%
1 drugs Phase 1: 2
Cardiovascular 33%
0 drugs Phase 3: 1
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2020-01-16
- Latest
- 2025-08-25
- Applications
- 2